AnazaoHealth
Warning letteri (Aug 2021), no closeout on file; a 2025 Form 483 followed, no second warning letter since.
About this pharmacy
Facility type: 503A/503B — licensed as both a state compounding pharmacyi and an FDA-registered outsourcing facility.
The four standards
No PCABi, NABP, or LegitScript confirmation found. This standard has not yet been fully researched for this pharmacy.
FDA warning letter issued August 18, 2021. No closeout letteri has been found. A Form 483i was issued on August 8, 2025, but no second warning letter has followed since.
(Method: checked against FDA’s public warning-letter, closeout-letter, and Form 483 databases.)
Source: FDA warning letter — August 2021
Source: FDA Form 483 — August 2025
This standard has not yet been checked for this pharmacy.
Several positive customer testimonials found, alongside at least one specific complaint describing a refill/shipping delay that caused a prescription to lapse.
(Method: assessed from patterns in public customer feedback.)
Frequently asked questions
Is AnazaoHealth accredited?
We have not confirmed accreditation for AnazaoHealth. No PCAB, NABP, or LegitScript confirmation found. This standard has not yet been fully researched for this pharmacy.
Has AnazaoHealth had any FDA regulatory actions?
Yes. FDA warning letter issued August 18, 2021. No closeout letter has been found. A Form 483 was issued on August 8, 2025, but no second warning letter has followed since. Checked against FDA’s public warning-letter, closeout-letter, and Form 483 databases.